Monster Experiment

June 11, 2001 “Monster Experiment” taught orphans to stutter The results of a covered up, 1939 children’s experiment demonstrates why AHRP calls for greater caution and mandatory safeguards in research involving children–even non-invasive research studies may cause children harm for life. The San Jose Mercury News (below) found evidence and…

Testimony Re: Research Involving Children

Submitted to the Office of Human Research Protection
by Vera Hassner Sharav and Marie M. Cassidy, Ph.D, D.Sc.

AHRP recognizes that to include children in clinical trials for any medication presents a dilemma of truly Solomonic proportions. It is a choice between continuing the practice of prescribing untested drugs for children, as is currently the operational system, or conducting meaningful trials to determine both safety and effectiveness.

Boston Globe series by Alice Dembner documents harm to children in clinical trials

Feb-March, 2001. Boston Globe series by Alice Dembner documents harm to children in clinical trials DANGEROUS DOSAGE Published on February 18, 2001. Author(s): Alice Dembner, Globe Staff TESTING CHILDREN’S DRUGS Published on March 18, 2001. TEDDY BEARS AND VEILED THREATS Published on March 20, 2001. Author(s): Alice Dembner, Globe Staff…

Seattle Times Series on Fred Hutchinson Cancer Center

Seattle Times Series on Fred Hutchinson Cancer Center 2001 Seattle Times Series, UNINFORMED CONSENT An in-depth, documented, 5-part investigative series, in The Seattle Times, beginning Sunday, March 11, 2001, turned the spotlight on cancer research at the world renowned Fred Hutchinson Cancer Center in Seattle — with supporting documents available…

Washington Post_Harvesting China’s Blood_installment 4

Washington Post_Harvesting China’s Blood_installment 4 December 20, 2000. Washington Post. In what is, so far, the most devastating installment in the Washington Post series about the unholly alliances that comprise the booming human research industry, America’s premier academic research center is shown–not only to have violated ethical research standards in…

Harvard-affiliated gene studies in China face federal inquiry

Harvard-affiliated gene studies in China face federal inquiry – Boston Globe. August 1, 2000. Harvard-affiliated gene studies in China face federal inquiry, by Deborah Nelson. Genetic research in China is booming. The biotech industry, in collaboration with scientists from America’s elite research centers & the U.S. government, is looking at…

| |

Chemically Induced Psychosis Experiments

Chemically Induced Psychosis Experiments: An Inhumane Paradigm in Psychiatric Research Congressional Testimony submitted by Vera Sharav * February 2, 2000 Statement For the Record Submitted To U.S. Senate Sub-Committee: Public Health & Safety of the Senate Health, Education, Labor & Pensions Committee Hearing Our efforts helped bring to public attention…

Chemically Induced Psychosis Experiments: An Inhumane Paradigm in Psychiatric Research


Congressional Testimony submitted by Vera Sharav

Statement For the Record Submitted to
The U.S. Senate Sub-Committee: Public Health & Safety of the Senate Health, Education, Labor & Pensions Committee Hearing

Our efforts helped bring to public attention major medical ethics violations in Federally-funded research in which uninformed, vulnerable American citizens are put at high risks without justification. As a result, such individuals have often suffered severe consequences – some have lost their lives unnecessarily. Based on the evidence – including testimonies by families and patients – we believe five factors contribute to unethical human experiments:

Evidence of Neuroleptic Drug-Induced Brain Damage in Patients


A partial, Annotated Bibliography by Vera Hassner Sharav

For distribution: January, 2000

Although patients, families and the public were not informed – some would argue they were deceived – clinical psychiatrists and researchers have long known about severe adverse drug reactions (ADR) and disabling changes in the central nervous system in a high percentage of patients taking standard neuroleptic drugs.